![]() ![]() The new MCOT™ device has a smaller sensor connected to patient leads (electrodes) that sends the ECG data via wireless transmission to the communication device (phone). ![]() This unit is slightly smaller in size & weight with 2 functioning modules. CardioNet originated a service company which has evolved into the industry giant with the acquisitions of prominent cardiac monitoring companies such as Braemar Instruments, Mednet Healthcare Technologies & Biomedical Systems’ (BMS) service division.ĬardioNet now claims to have the best MCT technology with their newest MCOT™ device. With them being in the MCT business the longest, they have made several different models for their Mobile Cardiac Outpatient Telemetry monitors. CardioNet relies on their brand name & their clinical strength (proven in published clinical studies) to separate their company among the competition.Īs we discussed, CardioNet was the inventor of Mobile Cardiac Outpatient Telemetry. CardioNet has a sound reputation for reliable service, advancing technology and a commitment to reducing healthcare costs related to ambulatory cardiac monitoring.Īlthough CardioNet remains the U.S leader by being the first to provide MCT technology, other companies are now introducing newer technology with comparable monitoring and service capabilities. With most emerging technologies, the phrase ‘the early bird gets the worm’ sums up the leadership of CardioNet’s in the Mobile Cardiac Telemetry market segment. When we speak of CardioNet as the pioneer, we can also credit them as the company that published the clinical work and brought reimbursement to Mobile Cardiac Telemetry studies in the U.S. The MCOT™ technology from CardioNet was the first to offer reliable real-time ECG monitoring solution where 24-48 Hour Holter monitoring & loop recording was not sufficient in capturing relevant clinical information. To CardioNet, ‘time is of the essence’ when diagnosing patients with significant cardiac arrhythmic disturbances. CardioNet opened its first diagnostic laboratory in 2002 in Philadelphia, PA and now traded on the NASDAQ (BEAT) under the holding company Bio Telemetry. The company was founded on the concept to close the gap on technological limitations of traditional cardiac monitoring (Holter and Event monitoring) to be able to monitor their patient’s heart beat (in real-time) on a beat by beat basis 24 hours a day, 7 days a week, 365 days a year. Starting back in 1999, CardioNet is the company that had the vision to take ambulatory monitoring to the next level. CardioNet can be crediting with virtually creating this form of Cardiac Monitoring technology as we have it today. In addition, the company said the study showed that using an MCOT patch followed by ILR in half of patients initially undiagnosed with AF leads to an overall cost-of-care savings of more than $4M.CardioNet is the most well-known company in the Mobile Cardiac Telemetry space for pioneering Mobile Cardiac Outpatient Telemetry or MCOT™.The study also showed that use of initial MCOT monitoring achieved almost eight times lower costs, reducing the total cost per patient with detected AF by ~$199K, compared to monitoring with ILR alone.The company said the study determined that a 30-day continuous monitoring program using the Philips BioTel Heart MCOT (mobile cardiac outpatient telemetry) patch, followed by an implantable loop recorder (ILR), improved AF detection rates and helped to reduce secondary stroke risk due to new anticoagulant use in people with the MCOT patch detected AF.AF is an irregular and rapid heart rhythm that can increase risk of stroke.Royal Philips (NYSE: PHG) said a study suggested that its BioTel Heart MCOT patch detected 4.6 times more patients with atrial fibrillation (AF) compared to implantable loop recorder alone. ![]()
0 Comments
Leave a Reply. |